Guba K. A levcromakalim kardioprotektiv hatásának vizsgálata izolált perfundált tengerimalac sziven. (1994) ACTA PHARMACEUTICA HUNGARICA 0001-6659 64 95-99,
1373891
Szakcikk (Folyóiratcikk) | Tudományos[1373891]
Xinrong X et al. The therapeutic effects of levcromakalim in patients with hypoxic pulmonary hypertension. (2002) Journal of West China University of Medical Sciences 0257-7712 33 4 504-506
Szentmiklosi A J et al. Adenosine receptors mediate both contractile and relaxant effects of adenosine in main pulmonary-artery of guinea-pigs. (1995) NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 0028-1298 1432-1912 351 4 417-425,
1373767
Szakcikk (Folyóiratcikk) | Tudományos[1373767]
Matthee Chrisna et al. Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development. (2021) MOLECULAR DIVERSITY 1381-1991 1573-501X
Burnstock Geoffrey et al. Purinergic Signaling and Blood Vessels in Health and Disease. (2014) PHARMACOLOGICAL REVIEWS 0031-6997 1521-0081 66 1 102-192
Koos BJ. Adenosine A(2a) receptors and O-2 sensing in development. (2011) AMERICAN JOURNAL OF PHYSIOLOGY: REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY 0363-6119 1522-1490 301 3 R601-R622
Leal S et al. Immunohistochemical Characterization of Adenosine Receptors in Rat Aorta and Tail Arteries. (2008) MICROSCOPY RESEARCH AND TECHNIQUE 1059-910X 71 10 p. 703-709
Lin C L et al. An adenosine A(1) receptor agonist preserves eNOS expression and attenuates cerebrovasospasm after subarachnoid haemorrhage. (2008) ACTA NEUROCHIRURGICA SUPPLEMENT 0065-1419 104 149-153
Lin C L et al. An adenosine A (1) receptor agonist preserves eNOS expression and attenuates cerebrovasosmasm after subarachnoid haemorrhage. (2008) ACTA NEUROCHIRURGICA SUPPLEMENT 0065-1419 104 149 p. 153
Coelho J. What animal models have taught us about adenosine receptor function. (2007) Immunology,endocrine and metabolic agents in medicinal chemistry 7 4 328-340
Chang C Z et al. The adenosine 2A receptor agonist ATL-146e attenuates experimental posthemorrhagic vasospasm. (2007) NEUROSURGERY 0148-396X 1524-4040 60 6 p. 1110-1117
Kalkan S et al. Effects of adenosine receptor antagonists on amitriptyline-induced vasodilation in rat isolated aorta. (2007) CLINICAL TOXICOLOGY 1556-3650 1556-9519 45 5 p. 600-604
Lin C L et al. Attenuation of experimental subarachnoid hemorrhage-induced cerebral vasospasm by the adenosine A(2A) receptor agonist CGS 21680. (2007) JOURNAL OF NEUROSURGERY 0022-3085 106 3 p. 436-441
Lin C L et al. The effect of an adenosine A1 receptor agonist in the treatment of experimental subarachnoid hemorrhage-induced cerebrovasospasm. (2006) ACTA NEUROCHIRURGICA 0001-6268 0942-0940 148 8 p. 873-879
Arulmani U et al. Lack of effect of the adenosine A(1) receptor agonist, GR79236, on capsaicin-induced CGRP release in anaesthetized pigs. (2005) CEPHALALGIA 0333-1024 1468-2982 25 11 1082-1090
Grigorevich S A. Diagnosthicheskie vozmosnosti registravii spontannoi bioelektritseskoi aktivnosti i mechanismi ismeninia funkcionalnogo sostaiania spinnogo mosga pri povresdenii. (2005)
Fresco P et al. Facilitation of noradrenaline release by activation of adenosine A(2A) receptors triggers both phospholipase C and adenylate cyclase pathways in rat tail artery. (2004) CARDIOVASCULAR RESEARCH 0008-6363 1755-3245 63 4 p. 739-746
Diniz C et al. Regional differences in the adenosine A(2) receptor-mediated modulation of contractions in rat vas deferens. (2003) EUROPEAN JOURNAL OF PHARMACOLOGY 0014-2999 1879-0712 460 2-3 p. 191-199
Lucas D G et al. Cardiorenal effects of adenosine subtype 1 (A(1)) receptor inhibition in an experimental model of heart failure. (2002) JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS 1072-7515 194 5 p. 603-609
Nieri P et al. Adenosine-mediated hypotension in in vivo guinea-pig: receptors involved and role of NO. (2001) BRITISH JOURNAL OF PHARMACOLOGY 0007-1188 1476-5381 134 4 p. 745-752
Ralevic V et al. Purinergic Receptors, Nitric Oxide and regional Blood Flow. (2000) Megjelent: Nitric Oxide and the Regulation of the Peripheral Circulation p. 83
Prior H M et al. Role of K+ channels in A(2A) adenosine receptor-mediated dilation of the pressurized renal arcuate artery. (1999) BRITISH JOURNAL OF PHARMACOLOGY 0007-1188 1476-5381 126 2 p. 494-500
Hakim T S et al. Segmental pulmonary vascular responses to ATP in rat lungs: Role of nitric oxide. (1997) JOURNAL OF APPLIED PHYSIOLOGY 8750-7587 1522-1601 82 3 p. 852-858
Danialou G et al. Predominant role of A(1) adenosine receptors in mediating adenosine induced vasodilatation of rat diaphragmatic arterioles: Involvement of nitric oxide and the ATP-dependent K+ channels. (1997) BRITISH JOURNAL OF PHARMACOLOGY 0007-1188 1476-5381 121 7 p. 1355-1363
Zhao Z H et al. An A3-subtype adenosine receptor is highly expressed in rat vascular smooth muscle cells: Its role in attenuating adenosine-induced increase in cAMP. (1997) MICROVASCULAR RESEARCH 0026-2862 1095-9319 54 3 p. 243-252
Maddock H L et al. Responses of guinea-pig isolated aorta and pulmonary artery to adenosine receptor agonists in normoxia and hypoxia. (1996) BRITISH JOURNAL OF PHARMACOLOGY 0007-1188 1476-5381 118 p. P96-P96
Szabó J Z et al. On the cardioprotective effect of adenosine. (1996) ACTA PHYSIOLOGICA HUNGARICA 0231-424X 1588-2683 2498-602X 84 3 337-338,
1373896
Rövid közlemény (Folyóiratcikk) | Tudományos[1373896]
Varela A et al. Lack of protective effects of adenosine on the hypoxic and reoxygenated atria and ventricular strips of the rat. (1999) JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY 1138-7548 55 1 17-24
Ujfalusi A et al. The effect of chronic diazepam treatment on hypoxia-induced alterations in functional activity of guinea pig myocardium. (1996) ACTA PHYSIOLOGICA HUNGARICA 0231-424X 1588-2683 2498-602X 84 3 345-346,
1941783
Szakcikk (Folyóiratcikk) | Tudományos[1941783]
Darrouj J et al. Cardiovascular Manifestations of Sedatives and Analgesics in the Critical Care Unit. (2009) AMERICAN JOURNAL OF THERAPEUTICS 1075-2765 16 4 339-353
Ujfalusi A et al. Sensitization by chronic diazepam treatment of A2A adenosine receptor-mediated relaxation in rat pulonary artery. (1999) LIFE SCIENCES 0024-3205 1879-0631 64 2 PL19-PL25,
1373900
Szakcikk (Folyóiratcikk) | Tudományos[1373900]
Boknik P. et al. Role of Cardiac A2A Receptors Under Normal and Pathophysiological Conditions. (2021) FRONTIERS IN PHARMACOLOGY 1663-9812 11
Darrouj J et al. Cardiovascular Manifestations of Sedatives and Analgesics in the Critical Care Unit. (2009) AMERICAN JOURNAL OF THERAPEUTICS 1075-2765 16 4 339-353
Varani K et al. Aberrant A (2A) receptor function in peripheral blood cells in Huntington's disease. (2003) FASEB JOURNAL 0892-6638 1530-6860 17 12 p. 2148
Seubert C N et al. Midazolam selectively potentiates the A (2A)- but not A (1)-receptor-mediated effects of adenosine. (2000) ANESTHESIOLOGY 0003-3022 1528-1175 92 2 567-577
Gatch M B. Effects of benzodiazepines on acute and chronic ethanol-induced nociception in rats. (1999) ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 0145-6008 1530-0277 23 11 1736-1743
Chioza BA et al. Mutations in the lysyl oxidase gene are not associated with amyotrophic lateral sclerosis. (2001) AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS 1466-0822 2167-9223 2167-8421 2 2 93-97,
2858658
Szakcikk (Folyóiratcikk) | Tudományos[2858658]
Keshri Anchal et al. Role of micronutrients during peri-parturient period of dairy animals - a review. (2019) BIOLOGICAL RHYTHM RESEARCH 0929-1016 1744-4179
Jourdan-Le Saux C et al. Central nervous system, uterus, heart and leukocyte expression of the LOXL3 gene, encoding a novel lysyl oxidase-like protein. (2001) GENOMICS 0888-7543 1089-8646 74 2 p. 211,
2858644
Szakcikk (Folyóiratcikk) | Tudományos[2858644]
Wei Qianhao. Apoptosis Activation and Autophagy Inhibition of Chondrocytes by Leptin by the Upregulation of LOXL3 in Osteoarthritis Pathogenesis. (2022) JOURNAL OF HEALTHCARE ENGINEERING 2040-2295 2022
Laurentino Talita de et al. LOXL3 Silencing Affected Cell Adhesion and Invasion in U87MG Glioma Cells. (2021) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 22 15
Yang N. et al. Lysyl oxidases: Emerging biomarkers and therapeutic targets for various diseases. (2020) BIOMEDICINE & PHARMACOTHERAPY 0753-3322 1950-6007 131
He Dan et al. LOXL2 from human amniotic mesenchymal stem cells accelerates wound epithelialization by promoting differentiation and migration of keratinocytes. (2020) AGING-US 1945-4589 12 13 12960-12986
Findlay A. et al. CHAPTER 5: Inhibition of LOXL2 and Other Lysyl Oxidase (Like) Enzymes: Intervention at the Core of Fibrotic Pathology. (2020) Megjelent: Anti-fibrotic Drug Discovery pp. 145-164
Laurentino Talita de et al. LOXL3 Function Beyond Amino Oxidase and Role in Pathologies, Including Cancer. (2019) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 20 14
Santamaria Patricia G et al. Lysyl oxidase-like 3 is required for melanoma cell survival by maintaining genomic stability. (2018) CELL DEATH AND DIFFERENTIATION 1350-9047 1476-5403 25 5 935-950
Salza Romain et al. The Multimerization State of the Amyloid-beta(42) Peptide (A beta(42)) Governs its Interaction Network with the Extracellular Matrix. (2017) JOURNAL OF ALZHEIMER'S DISEASE 1387-2877 1875-8908 56 3 991-1005
Jeong Chankyu et al. LOXL3-sv2, a novel variant of human lysyl oxidase-like 3 (LOXL3), functions as an amine oxidase. (2017) INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 1107-3756 1791-244X 39 3 719-724
Dudakova Lubica et al. The presence of lysyl oxidase-like enzymes in human control and keratoconic corneas. (2016) HISTOLOGY AND HISTOPATHOLOGY 0213-3911 1699-5848 31 1 63-71
Trackman Philip C. Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer. (2016) EXPERT OPINION ON THERAPEUTIC TARGETS 1472-8222 1744-7631 20 8 935-945
Li Jiali et al. Exome sequencing identified null mutations in LOXL3 associated with early-onset high myopia. (2016) MOLECULAR VISION 1090-0535 22 161-167
Li Haibin et al. Mechano growth factor-E regulates apoptosis and inflammatory responses in fibroblast-like synoviocytes of knee osteoarthritis. (2015) INTERNATIONAL ORTHOPAEDICS 0341-2695 1432-5195 39 12 2503-2509
Sharma-Bhandari Anjali et al. Lysyl oxidase modulates the osteoblast differentiation of primary mouse calvaria cells. (2015) INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 1107-3756 1791-244X 36 6 1664-1670
Zhang Jian et al. Loss of lysyl oxidase-like 3 causes cleft palate and spinal deformity in mice. (2015) HUMAN MOLECULAR GENETICS 0964-6906 1460-2083 24 21 6174-6185
Wang CL et al. Differential expressions of the lysyl oxidase family and matrix metalloproteinases-1, 2, 3 in posterior cruciate ligament fibroblasts after being co-cultured with synovial cells. (2015) INTERNATIONAL ORTHOPAEDICS 0341-2695 1432-5195 39 1 183-191
Wu BL et al. Exploration of Potential Roles of a New LOXL2 Splicing Variant Using Network Knowledge in Esophageal Squamous Cell Carcinoma. (2014) SCIENTIFIC WORLD JOURNAL 1537-744X 2356-6140
Ahn Sung et al. LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients. (2013) BREAST CANCER RESEARCH AND TREATMENT 0167-6806 1573-7217 141 1 89-99
Li TY et al. Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase-like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. (2012) HUMAN PATHOLOGY 0046-8177 1532-8392 43 7 1068-1076
Kim EC et al. Lysyl Oxidase and the Lysyl Oxidase-like Protein Modulate Odontoblastic Differentiation of Human Dental Pulp Cells. (2012) JOURNAL OF ENDODONTICS 0099-2399 38 6 769-773
Kim YM et al. The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin. (2011) MOLECULAR BIOLOGY REPORTS 0301-4851 1573-4978 38 1 145-149
van Boxtel AL et al. Lysyl oxidase-like 3b is critical for cartilage maturation during zebrafish craniofacial development. (2011) MATRIX BIOLOGY 0945-053X 30 3 178-187
Fujimoto E et al. Reciprocal regulation of LOX and LOXL2 expression during cell adhesion and terminal differentiation in epidermal keratinocytes. (2009) JOURNAL OF DERMATOLOGICAL SCIENCE 0923-1811 1873-569X 55 2 91-98
Maki JM. Lysyl oxidases in mammalian development and certain pathological conditions. (2009) HISTOLOGY AND HISTOPATHOLOGY 0213-3911 1699-5848 24 5 651-660
Akagawa H et al. Systematic screening of lysyl oxidase-like (LOXL) family genes demonstrates that LOXL2 is a susceptibility gene to intracranial aneurysms. (2007) HUMAN GENETICS 0340-6717 1432-1203 121 3-4 377-387
Payne SL et al. Paradoxical roles for lysyl oxidases in cancer - A prospect. (2007) JOURNAL OF CELLULAR BIOCHEMISTRY 0730-2312 1097-4644 101 6 1338-1354
Sato T et al. Comparative analysis of gene, expression profiles in intact and damaged regions of human osteoarthritic cartilage. (2006) ARTHRITIS AND RHEUMATISM 0004-3591 1529-0131 2326-5205 54 3 808-817
Lee JE et al. A tissue-specific variant of the human lysyl oxidase-like protein 3 (LOXL3) functions as an amine oxidase with substrate specificity. (2006) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 281 49 37282-37290
Geach TJ et al. Members of the lysyl oxidase family are expressed during the development of the frog Xenopus laevis. (2005) DIFFERENTIATION 0301-4681 1432-0436 73 8 414-424
Maki JM et al. Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. (2005) AMERICAN JOURNAL OF PATHOLOGY 0002-9440 1525-2191 167 4 927-936
Atsawasuwan P et al. Expression of lysyl oxidase isoforms in MC3T3-El osteoblastic cells. (2005) BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 0006-291X 1090-2104 327 4 1042-1046
Vadasz Z et al. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2. (2005) JOURNAL OF HEPATOLOGY 0168-8278 1600-0641 43 3 499-507
Sarrias MR et al. The scavenger receptor cysteine-rich (SRCR) domain: An ancient and highly conserved protein module of the innate immune system. (2004) CRITICAL REVIEWS IN IMMUNOLOGY 1040-8401 24 1 1-37
Kagan HM et al. Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell. (2003) JOURNAL OF CELLULAR BIOCHEMISTRY 0730-2312 1097-4644 88 4 660-672
Hornstra IK et al. Lysyl oxidase is required for vascular and diaphragmatic development in mice. (2003) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 278 16 14387-14393
Martins RP et al. Characterization of the region encompassing the human lysyl oxidase locus. (2001) DNA SEQUENCE 1042-5179 1029-2365 12 4 p. 215,
2858678
Szakcikk (Folyóiratcikk) | Tudományos[2858678]
Wang Min et al. Comparison of the biomechanics and fixation index of crosslinking between lysyl oxidase and genipin on guinea pig sclera, an animal model of defocus-induced high myopia. (2019) PROCEEDINGS OF THE ESTONIAN ACADEMY OF SCIENCES 1736-6046 68 2 214-221
Reuven NB et al. The UL12.5 gene product of herpes simplex virus type 1 exhibits nuclease and strand exchange activities but does not localize to the nucleus. (2004) JOURNAL OF VIROLOGY 0022-538X 1098-5514 78 9 4599-4608
Porter IM et al. Replication, recombination and packaging of amplicon DNA in cells infected with the herpes simplex virus type 1 alkaline nuclease null mutant ambUL12. (2004) JOURNAL OF GENERAL VIROLOGY 0022-1317 1465-2099 85 3501-3510
Britt WJ et al. Rapid genetic engineering of human cytomegalovirus by using a lambda phage linear recombination system: Demonstration that pp28 (UL99) is essential for production of infectious virus. (2004) JOURNAL OF VIROLOGY 0022-538X 1098-5514 78 1 539-543
Csiszár K et al. Somatic mutations of the lysyl oxidase gene on chromosome 5q23.1 in colorectal tumors. (2002) INTERNATIONAL JOURNAL OF CANCER 0020-7136 1097-0215 97 5 636-642,
2858638
Szakcikk (Folyóiratcikk) | Tudományos[2858638]
Kim Min-Seob et al. Extracellular Matrix Biomarkers in Colorectal Cancer. (2021) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 22 17
Chen Jingyi et al. Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer. (2021) BMC CANCER 1471-2407 1471-2407 21 1